Observational Study on the Patients With Pain Medications

Pain Clinical Trial

Official title:

Observational Study on the Patients With Pain Medications

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00771212
• Other study ID #: CR014656
• Status: Completed
• Phase: Phase 4
• First received: October 10, 2008
• Last updated: May 22, 2014
• Start date: October 2007
• Est. completion date: May 2008

Study information

• Verified date: May 2014
• Source: Johnson & Johnson Taiwan Ltd
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to describe the use of pain treatments in Taiwan, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment.

Description:

This is a Phase IV, multi-center, observational study to describe the use of pain treatments, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment. The study is conducted in an effort to understand the status of pain control in Taiwan. Currently in Taiwan, there is no approved documentation showing the most effective standard medication for treatment of patients in pain. Observational study with no study medication administered.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2636
• Est. completion date: May 2008
• Est. primary completion date: May 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Outpatients only

• Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time

• Patient must have a VAS score >4

Exclusion Criteria:

• Patients who are receiving any investigational drug during the study

• Patients with known or suspected psychotic disease or mental retardation.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pain

Intervention

Other:
• Observational pain control study
Observational pain control study

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Johnson & Johnson Taiwan Ltd

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan		60 days	No
Secondary	Pain Relief Rating Scale		60 days	No
Secondary	Sleeping quality Assessment		60 days	No
Secondary	Global Assessments (Patient/Investigator)		60 days	No